Mi Heon Ryu

3.4k citations
70 papers · 2.8k indexed · h-index 26

Mi Heon Ryu

61 papers receiving 2.8k citations

Peers

Mi Heon Ryu
Comparison fields: 5 of 115
  • Nephrology 770
  • Immunology 832
  • Periodontics 87
  • Molecular Biology 1.1k
  • Immunology and Allergy 97
Replace István Arany with:
István Arany United States
Yoshitaka Hosokawa Japan
Patrice E. Poubelle Canada
Paolo Geñtilini Italy
Henning W. Zimmermann Germany
Christoph H. Österreicher Austria
Michael Torzewski Germany
Yao Wang China
Shuang Liang China
Shih‐Chi Su Taiwan
Mi Heon Ryu relative to István Arany United States István Arany's profile →
Citations per field
00.5×2.6×
István Arany · 1×
Citations per year

Countries citing papers authored by Mi Heon Ryu

Since Specialization
Citations

This map shows the geographic impact of Mi Heon Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Heon Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Heon Ryu more than expected).

Fields of papers citing papers by Mi Heon Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Heon Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Heon Ryu. The network helps show where Mi Heon Ryu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mi Heon Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mi Heon Ryu Line = papers co-authored together Mi Heon Ryu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20240
4 20210
5 202019
6 20191
7 201817
8 20170
9 20157
10 201514
11 201410
12 201410
13 201285
14 2012127
15 2012351
16 20110
17 201147
18 201194
19 201154
20 201058

About Mi Heon Ryu

Mi Heon Ryu is a scholar working on Nephrology, Cancer Research, Oral Surgery, Otorhinolaryngology and Dermatology, having authored 70 papers that have together received 2.8k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (6 papers), Oral and Maxillofacial Pathology (6 papers), Tumors and Oncological Cases (5 papers), Cancer-related Molecular Pathways (4 papers), Natural product bioactivities and synthesis (4 papers), Cell death mechanisms and regulation (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Nephrology (770 citations), Immunology (832 citations), Periodontics (87 citations), Molecular Biology (1.1k citations) and Immunology and Allergy (97 citations). Mi Heon Ryu has collaborated with scholars based in South Korea, Germany and United States. Frequent co-authors include Hans‐Joachim Anders, Shrikant R. Mulay, Onkar P. Kulkarni, Murthy N. Darisipudi, Dana Thomasová, Oliver Groß, Julia Lichtnekert, Helen Liapis, Eka Susanti and Maciej Lech. Their work appears in journals such as Journal of the American Society of Nephrology, Kidney International, Pharmacognosy Magazine, The Journal of Pathology and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026